Targeting Androgen Receptor Signaling as a Therapeutic Strategy for Women With Triple-Negative Breast Cancer

Clinical Focus - Denise A. Yardley, MD, explores key agents in one of the most promising investigational treatment approaches for patients with TNBC: inhibition of androgen pathway signaling.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research